While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

A feedback system lets the body know when no more glucagon is needed. When everything works correctly, the body will produce insulin to move glucose out of the blood and into the cells to ...

Research shows short-term fasting improves glucose regulation, while long-term fasting in young mice impairs β cell function, ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...